FULC vs GILD: Which Stock is Better?

Side-by-side comparison of Fulcrum Therapeutics Inc and Gilead Sciences Inc in 2026

Comparison Updated:

FULC

Fulcrum Therapeutics Inc

$8.29

GILD

Gilead Sciences Inc

$137.64

Key Metrics Comparison

MetricFULCGILDWinner
Market Cap$552.12M$170.84BGILD
P/E RatioN/A20.27GILD
EPS (TTM)$N/A$6.79GILD
Revenue Growth-1.0%0.0%GILD
Gross Margin0.0%78.8%GILD

Analyze FULC

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is FULC or GILD a better investment?

Comparing FULC and GILD: Fulcrum Therapeutics Inc has a market cap of $552.12M while Gilead Sciences Inc has $170.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between FULC and GILD?

FULC (Fulcrum Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: FULC or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: FULC or GILD?

GILD has higher revenue growth at 0.0% vs -1.0% for FULC.

Which company is more profitable: FULC or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for FULC.

Which is the larger company: FULC or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $170.84B compared to $552.12M for FULC.

Should I buy FULC or GILD in 2026?

Both FULC and GILD have investment merit. FULC trades at $8.29 while GILD trades at $137.64. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between FULC and GILD stock?

Key differences: Market Cap ($552.12M vs $170.84B), P/E Ratio (N/A vs 20.3x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).

Popular Stock Comparisons